Publications:165
Donna Mildvan, MD
Infectious Disease
No Patient Experience Ratings
About Me
Donna Mildvan, MD, Fellow, American College of Physicians; Fellow, Infectious Diseases Society of America; Attending in Medicine, Infectious Diseases, Mount Sinai Beth Israel; Professor of Medicine, Icahn School of Medicine at Mount Sinai; formerly Chief, Division of Infectious Diseases/AIDS, Mount Sinai Beth Israel. Dr. Mildvan was Co-Principal Investigator/Principal Investigator, AIDS Clinical Trials Group (1987-2008) and responsible for early descriptions of AIDS and complications of HIV infection, including the lymphadenopathy syndrome, and investigations demonstrating LAV (HIV) in the first US AIDS cases and the first convincing evidence that the brain harbored and could transmit HIV. Research focus includes antiretroviral drug development, innovation in biomarker research and study design, championing diversity in clinical trials participation, and optimizing management of community acquired pneumonia and antimicrobial prescribing to reduce emergence of drug resistance.
Language
English
Position
CLINICAL PROFESSOR | Medicine, Infectious Diseases
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Antimicrobial Resistance, Community-acquired Pneumonia, HIV/AIDS
Clinical Focus
- HIV and AIDS
- Pneumonia
Education
MD, Johns Hopkins University School of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Infectious Disease
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Research
HIV/AIDS
Community Acquired Pneumonia
Community Acquired Pneumonia
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Julio A. Ramirez, Daniel M. Musher, Scott E. Evans, Charles Dela Cruz, Kristina A. Crothers, Chadi A. Hage, Stefano Aliberti, Antonio Anzueto, Francisco Arancibia, Forest Arnold, Elie Azoulay, Francesco Blasi, Jose Bordon, Steven Burdette, Bin Cao, Rodrigo Cavallazzi, James Chalmers, Patrick Charles, Jean Chastre, Yann Erick Claessens, Nathan Dean, Xavier Duval, Muriel Fartoukh, Charles Feldman, Thomas File, Filipe Froes, Stephen Furmanek, Martin Gnoni, Gustavo Lopardo, Carlos Luna, Takaya Maruyama, Rosario Menendez, Mark Metersky, Donna Mildvan, Eric Mortensen, Michael S. Niederman, Mathias Pletz, Jordi Rello, Marcos I. Restrepo, Yuichiro Shindo, Antoni Torres, Grant Waterer, Brandon Webb, Tobias Welte, Martin Witzenrath, Richard Wunderink. Chest
- Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: A real-world US insurance claims database study. Glenn Tillotson, Thomas Lodise, Peter Classi, Donna Mildvan, James A. McKinnell. Open Forum Infectious Diseases
- Efavirenz therapeutic range in HIV-1 treatment-naive participants. Cindy J. Bednasz, Charles S. Venuto, Qing Ma, Eric S. Daar, Paul E. Sax, Margaret A. Fischl, Ann C. Collier, Kimberly Y. Smith, Camlin Tierney, Yang Yang, Gregory E. Wilding, Gene D. Morse, Hector H. Bolivar, Sandra Navarro, Susan L. Koletar, Diane Gochnour, Edward Seefried, Julie Hoffman, Judith Feinberg, Michelle Saemann, Kristine Patterson, Donna Pittard, David Currin, Kerry Upton, Michael Saag, Graham Ray, Steven Johnson, Bartolo Santos, Connie A. Funk, Michael Morgan, Brenda Jackson, Pablo Tebas, Aleshia Thomas, Ge Youl Kim, Michael K. Klebert, Jorge L. Santana, Santiago Marrero, Jane Norris, Sandra Valle, Gary Matthew Cox, Martha Silberman, Sadia Shaik, Ruben Lopez, Margie Vasquez, Demetre Daskalakis, Christina Megill, Todd Stroberg, Jessica Shore, Babafemi Taiwo, Donna Mildvan. Therapeutic Drug Monitoring
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Mildvan has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.